Boston, United States
AI Proteins, based in Boston, is a forward-thinking biotech startup founded in 2021. Focused on revolutionizing protein therapeutics, the company employs a fusion of AI-enabled design with a high-throughput drug discovery platform to create novel miniproteins for diverse therapeutic applications. This strategic approach defines the company’s mission captured in its slogan: "The perfect medicine is not found."
With a recent influx of $41.50M from a Series A round concluded on 01 November 2025, led by key industry players Santé Ventures and Mission BioCapital, AI Proteins is poised for significant growth. The company’s partnerships with leading biopharmaceutical firms enable it to pursue a wide array of collaborations, supporting both its external partnerships and internal project pipeline.
The company operates at the cutting edge of several intersecting industries, including AI, Biotechnology, Health and Wellness, and Pharmaceutical. This positions it well to impact the landscape of therapeutic development by accelerating the readiness of lead candidates for IND-enabling studies.
BioMap
